Abstract:AbstractBackgroundAlzheimer’s disease (AD) is a progressive and debilitating neurological disorder that impacts millions of individuals globally. Prompt and accurate detection and diagnosis of Alzheimer’s disease are pivotal for providing effective care and management to patients. However, early identification of the disease remains challenging due to the complexity of diagnostic procedures and the similarity of symptoms with age‐related cognitive decline. With the world transitioning towards a more digital‐focused environment, there is an increasing potential to utilize human‐computer interaction technologies to aid in the early detection of Alzheimer’s disease.MethodWe recruited 40 healthy individuals, 40 patients with mild cognitive impairment (MCI), and 40 patients with early AD. By incorporating fusion perception‐enhancing technologies into intelligent identification devices, such as eye‐tracking and body motion detection, peripheral modal biometric information can be gathered from subjects.ResultThe study found that in human‐computer interaction experiments using eye‐tracking, the patients with early AD showed significantly longer completion times and free rates of eye motion and movement trajectory than the normal group and those with MCI. The correlation between eye motion trajectory and movement trajectory was notably lower as compared to the normal group and the MCI group. During the human‐computer interaction physical movement experiment, the AD group recorded lower target accuracy rate and screen click rate as compared to the normal group and patients with MCI. Similarly, in the human‐computer interaction clock drawing experiment, the AD group demonstrated longer completion time and pen‐up thinking time, as well as lower clock drawing scores. Furthermore, the total completion time of human‐computer interaction tasks was notably shorter as compared to conventional cognitive screening tests. In conclusion, peripheral biomarkers obtained from the aforementioned human‐computer interaction task were analyzed using machine learning techniques, resulting in the identification of early‐stage Alzheimer’s disease with a classification accuracy of 91.1%.ConclusionHence, this non‐invasive and accurate technique may prove instrumental in identifying potential cognitive deficits associated with this disease while also being widely applicable for screening early AD.

Eyes: The Gateway to Brain Health—Advancing Disease Detection and Patient Accessibility

Digitized Biomarkers Utilizing Human‐Computer Interaction Sensing Technology for Early Auxiliary Diagnosis of Alzheimer’s Disease

When Eye-Tracking Meets Machine Learning: A Systematic Review on Applications in Medical Image Analysis

Imaging the eye as a window to brain health: frontier approaches and future directions

Advancements in eye movement measurement technologies for assessing neurodegenerative diseases

Eye tracking technology in medical practice: a perspective on its diverse applications

Diagnosing Systemic Disorders with AI Algorithms Based on Ocular Images

Eye Tracking to Assess the Functional Consequences of Vision Impairment: A Systematic Review

Eye-tracking in Mixed Reality for Diagnosis of Neurodegenerative Diseases

Eye tracking metrics to screen and assess cognitive impairment in patients with neurological disorders

Retina Oculomics in Neurodegenerative Disease

Eye Movement Research in the Twenty-First Century—a Window to the Brain, Mind, and More

Accelerating eye movement research via accurate and affordable smartphone eye tracking

AI enhanced eye detection wheelchair with smart monitoring using deep learning

Artificial Intelligence (AI) enable advanced and accurate diagnostics eye health station for critical eye conditions

Beyond Vision: Potential Role of AI-enabled Ocular Scans in the Prediction of Aging and Systemic Disorders

Detecting Abnormal Eye Movements in Patients with Neurodegenerative Diseases - Current Insights

Artificial Intelligence in Eye Movements Analysis for Alzheimer's Disease Early Diagnosis

Artificial intelligence in ophthalmology: an insight into neurodegenerative disease

Contribution of Eye-Tracking to Study Cognitive Impairments Among Clinical Populations

The AI Revolution in Glaucoma: Bridging Challenges with Opportunities